SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB/A - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]: [Amend]
SEC Accession No. 0000950120-08-000260
Filing Date
2008-06-06
Accepted
2008-06-06 14:32:42
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-KSB form-10ksba.htm 10KSB/A 1188106
2 CONSENT OF TABRIZTCHI & CO. CPA, P.C. exh23.htm EX-23 5302
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PUR exh31.htm EX-31 18578
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PUR exh32.htm EX-32 8377
5 TABRIZTCHI & CO. CPA, P.C. LETTERHEAD tabriztchi-letterhead.jpg GRAPHIC 32983
  Complete submission text file 0000950120-08-000260.txt   1267391
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB/A | Act: 34 | File No.: 000-19879 | Film No.: 08885316
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences